Varenicline (Varenicline) 0.5 mg / 1 mg

KITORALMacleods Pharmaceuticals LimitedNDC: 33342-577Updated: Mar 2026

Active Ingredients

Anhydrous Dibasic Calcium Phosphate

Filler/Binder

Hydroxypropyl Cellulose (1600000 Wamw)

Binder/Coating

Hypromellose 2910 (6 Mpa.s)

Coating/Binder

Magnesium Stearate

Lubricant

Microcrystalline Cellulose

Filler/Binder

Titanium Dioxide

Colorant/Opacifier

Ingredient	Purpose	Common Allergen?	Description
Anhydrous Dibasic Calcium Phosphate	Filler/Binder	No	A water-free calcium phosphate salt used as a filler, binder, and source of calcium in tablet formulations.
Hydroxypropyl Cellulose (1600000 Wamw)	Binder/Coating	No	A high-molecular-weight cellulose derivative used as a binder and film-coating agent. Plant-derived.
Hypromellose 2910 (6 Mpa.s)	Coating/Binder	No	A specific grade of hydroxypropyl methylcellulose (HPMC) used as a film-coating agent and binder. Plant-derived cellulose polymer.
Magnesium Stearate	Lubricant	No	A lubricant that prevents ingredients from sticking to manufacturing equipment.
Microcrystalline Cellulose	Filler/Binder	No	Refined wood pulp used as a filler and binder. Generally inert and well-tolerated.
Titanium Dioxide	Colorant/Opacifier	No	A white pigment used for coating opacity. Under regulatory review in some countries.

This medication contains ingredients flagged in the following groups. Patients with these sensitivities should consult their prescriber.

1 ingredient may contain mammalian-derived components:

Magnesium Stearate(Possible — Stearates can be plant- or animal-derived (verify source).)